ShangBay Capital
Mr. Engelson, is currently a board member and strategic advisor to Arrinex, Inc and ARANZ Medical, Ltd. Prior to this, he was CEO of Medina Medical, which he sold to Medtronic. Previous associations include Partner at The Foundry, a medical device incubator, CEO of two Foundry companies, CFO of Fluidigm Corporation, and as a Venture Partner at both Versant Ventures and Institutional Venture Partners.
Earlier in his career, Mr. Engelson spent 13 years in various operating roles at Target Therapeutics where he led the early-stage startup into the then-nascent field of Interventional Neuroradiology, developing its first products and helped take the company public. He is also the inventor of 50+ medical device patents.
Mr. Engelson holds B.A. and M.S. degrees in Microbiology and Bioengineering from UC San Diego, and an Executive MBA from the Stanford Graduate School of Business.
This person is not in any offices
ShangBay Capital
ShangBay Capital is a venture capital company that brings both U.S. and Chinese investors access to best-in-class investments in the U.S. medical devices technology, biotechnology, and mobile healthcare sectors through early-stage venture equity participation.